Cargando…
Accessing neuroinflammation sites: Monocyte/neutrophil-mediated drug delivery for cerebral ischemia
Cerebral ischemia (CI) results from inadequate blood flow to the brain. The difficulty of delivering therapeutic molecules to lesions resulting from CI hinders the effective treatment of this disease. The inflammatory response following CI offers a unique opportunity for drug delivery to the ischemi...
Autores principales: | Hou, Jia, Yang, Xu, Li, Shiyi, Cheng, Zhekang, Wang, Yuhua, Zhao, Jing, Zhang, Chun, Li, Yongji, Luo, Man, Ren, Hongwei, Liang, Jianming, Wang, Jue, Wang, Jianxin, Qin, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737273/ https://www.ncbi.nlm.nih.gov/pubmed/31531392 http://dx.doi.org/10.1126/sciadv.aau8301 |
Ejemplares similares
-
Neuroprotective Effects of Ginsenosides against Cerebral Ischemia
por: Cheng, Zhekang, et al.
Publicado: (2019) -
Surface modification of PGP for a neutrophil–nanoparticle co-vehicle to enhance the anti-depressant effect of baicalein
por: Chen, Baoyu, et al.
Publicado: (2018) -
Dyslipidemic Diet Induces Mobilization of Peripheral Neutrophils and Monocytes That Exacerbate Hemorrhagic Brain Injury and Neuroinflammation
por: Li, Xiuping, et al.
Publicado: (2020) -
Direct Macromolecular Drug Delivery to Cerebral Ischemia Area using Neutrophil-Mediated Nanoparticles
por: Zhang, Chun, et al.
Publicado: (2017) -
E3 Ubiquitin Ligase FBXO3 Drives Neuroinflammation to Aggravate Cerebral Ischemia/Reperfusion Injury
por: Gao, Yu, et al.
Publicado: (2022)